Tower Research Capital (TRC)’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$963K Buy
+33,223
New +$967K 0.03% 553
2025
Q4
Sell
-3,861
Closed -$93.9K 5344
2025
Q3
$93.9K Buy
3,861
+3,485
+927% +$80.2K ﹤0.01% 2039
2025
Q2
$7.95K Sell
376
-13,540
-97% -$278K ﹤0.01% 4031
2025
Q1
$295K Sell
13,916
-14,145
-50% -$314K 0.01% 1153
2024
Q4
$604K Buy
28,061
+16,768
+148% +$387K 0.01% 932
2024
Q3
$269K Sell
11,293
-1,417
-11% -$33.8K 0.01% 1352
2024
Q2
$289K Buy
12,710
+12,641
+18,320% +$276K ﹤0.01% 1797
2024
Q1
$1.53K Sell
69
-9,276
-99% -$206K ﹤0.01% 5250
2023
Q4
$205K Sell
9,345
-3,840
-29% -$75.6K ﹤0.01% 2085
2023
Q3
$261K Sell
13,185
-14,761
-53% -$301K 0.01% 1270
2023
Q2
$571K Buy
27,946
+11,122
+66% +$233K 0.02% 881
2023
Q1
$348K Buy
16,824
+2,618
+18% +$54.9K 0.01% 1049
2022
Q4
$299K Sell
14,206
-23,443
-62% -$485K 0.01% 1021
2022
Q3
$712K Sell
37,649
-5,415
-13% -$107K 0.01% 880
2022
Q2
$811K Sell
43,064
-3,289
-7% -$62.7K 0.02% 825
2022
Q1
$970K Buy
46,353
+28,787
+164% +$597K 0.01% 799
2021
Q4
$417K Buy
17,566
+8,182
+87% +$199K 0.01% 1234
2021
Q3
$240K Sell
9,384
-316,245
-97% -$8.33M 0.01% 1641
2021
Q2
$8.44M Buy
+325,629
New +$8.28M 0.22% 63

Other funds holding IBBQ

Tower Research Capital (TRC)'s IBBQ Position: Q1 2026 in Review

Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF (IBBQ) in Q1 2026: 33,223 shares worth $963K. The stake represents 0.03% of the portfolio and ranks #553 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in IBBQ as recently as Q3 2025.

Tower Research Capital (TRC) first reported a position in IBBQ in Q2 2021 and has held it in 19 quarters since. The position peaked at $8.44M in Q2 2021. 40 funds tracked by Wall St. Rank hold IBBQ as of Q1 2026.

  • Tower Research Capital (TRC) held 33,223 shares of Invesco NASDAQ Biotechnology ETF worth $963K as of Q1 2026.
  • Invesco NASDAQ Biotechnology ETF was a new Tower Research Capital (TRC) position in Q1 2026.
  • Invesco NASDAQ Biotechnology ETF made up 0.03% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #553 holding.
  • Tower Research Capital (TRC) first reported a position in Invesco NASDAQ Biotechnology ETF in Q2 2021 and has held it in 19 quarters since.
  • Tower Research Capital (TRC)'s Invesco NASDAQ Biotechnology ETF position peaked at $8.44M in Q2 2021.
  • 40 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.